Prevalence of Fms‐Like Tyrosine Kinase 3 (FLT3) Mutations in Patients With Acute Myeloid Leukaemia: A Systematic Literature Review and Meta‐Analysis

Documenti analoghi

• Changes in Common Blood Parameters After Discontinuation of Tyrosine Kinase Inhibitors for Chronic Myeloid Leukaemia
  di: Fiona Fernando, et al.
  Pubblicazione: (2025)
• Phase 2 Multi‐Arm Study of Magrolimab Combinations in Patients With Acute Myeloid Leukaemia
  di: Gabriel N. Mannis, et al.
  Pubblicazione: (2025)
• Phase I / II Trial of the FLT3 Kinase Inhibitor XY0206 in Patients With Relapsed/Refractory Acute Myeloid Leukemia
  di: Lin Song, et al.
  Pubblicazione: (2026)
• Acute Myeloid Leukaemia With Morphologic and Immunophenotypic Differentiation to Acute Erythroid Leukaemia at the Time of Relapse
  di: Katie Liston, et al.
  Pubblicazione: (2024)
• Paediatric Acute Myeloid Leukaemia–Myelodysplasia Related With i(17)(q10) Morphologically Mimicking Acute Promyelocytic Leukaemia
  di: Kathleen De John, et al.
  Pubblicazione: (2025)